HDAC8 and neuroblastoma: HDAC8 is either overexpressed or dysregulated in cancers, such as neuroblastoma, breast cancer, colon cancer (Nakagawa et al., 2007; Oehme et al., 2009; Park et al., 2011) and hematological malignancies.